A preponderance of evidence has illustrated that decreased serum Neuregulin 4 (Nrg4) level is detected in NAFLD patients and it is independently correlated with NAFLD, whilst its deficiency accelerates the process of inflammation, liver injury, and fibrosis, and in NASH mice[32, 33]. This evidence concerns the gene NRG4 and metabolic dysfunction-associated steatohepatitis.